stock.name

Akebia Therapeutics Inc.

AKBA

Market Cap$427.12M
Close$

Compare Akebia Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Akebia Therapeutics Inc.Akebia Therapeutics Inc.-8.20%170%--1.4
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$3.25

Current Fair Value

45.2% upside

Undervalued by 45.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$427.12 Million
Enterprise Value$427.82 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.28
Beta1.12
Outstanding Shares209,372,275
Avg 30 Day Volume4,047,201

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-8.23
PEG8.27
Price to Sales-
Price to Book Ratio-2.24
Enterprise Value to Revenue2.2
Enterprise Value to EBIT-9.29
Enterprise Value to Net Income-9
Total Debt to Enterprise0.1
Debt to Equity-1.43

Revenue Sources

No data

ESG Score

No data

About Akebia Therapeutics Inc.

CEO: John Butler